Koshi Mimori

425 citations
16 papers · 361 indexed · h-index 10
Topics
Amino Acid Enzymes and Metabolism (3 papers)Peptidase Inhibition and Analysis (3 papers)Polyamine Metabolism and Applications (3 papers)
Partner nations
JapanUnited States

In The Last Decade

Koshi Mimori

12 papers receiving 356 citations

Peers

Koshi Mimori
Comparison fields: 5 of 57
  • Oncology 150
  • Molecular Biology 142
  • Cancer Research 94
  • Surgery 75
  • Pathology and Forensic Medicine 75
Replace K Ito with:
K Ito Japan
Shao-Chieh Lin Taiwan
Shoichiro Mukai Japan
Ji-Hai Yu China
Hongming Qiu United States
Terence W. McGarvey United States
Áron Somorácz Hungary
Sporn Mb United States
Eric Schordan France
Takehiro Wakasugi Japan
Koshi Mimori relative to K Ito Japan K Ito's profile →
Citations per field
00.5×1.5×1.9×
K Ito · 1×
Citations per year

Countries citing papers authored by Koshi Mimori

Since Specialization
Citations

This map shows the geographic impact of Koshi Mimori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koshi Mimori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koshi Mimori more than expected).

Fields of papers citing papers by Koshi Mimori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koshi Mimori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koshi Mimori. The network helps show where Koshi Mimori may publish in the future.

Co-authorship network of co-authors of Koshi Mimori

This figure shows the co-authorship network connecting the top 25 collaborators of Koshi Mimori. A scholar is included among the top collaborators of Koshi Mimori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koshi Mimori. Koshi Mimori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 2
6 32
7 85
8 14
9 14
10 23
11
Increased expression of ornithine decarboxylase messenger RNA in human esophageal carcinoma.
20
12 15
13 6
14 83
15 34
16 33

About Koshi Mimori

Koshi Mimori is a scholar working on Biochemistry, Immunology and Allergy and Oncology, having authored 16 papers that have together received 361 indexed citations. Recurring topics across this work include Amino Acid Enzymes and Metabolism (3 papers), Peptidase Inhibition and Analysis (3 papers) and Polyamine Metabolism and Applications (3 papers). The work is most often cited by research in Cancer Research (94 citations), Oncology (150 citations) and Immunology and Allergy (29 citations). Koshi Mimori has collaborated with scholars based in Japan and United States. Frequent co-authors include Masaki Mori, Hiroshi Inoue, Yoïchi Tanaka, Masaki Mori, Keiji Yoshinaga, Masahiro Okamoto, Keishi Yamashita, Hiroaki Ueo, Toshihiko Masuda and Masaru Haraguchi. Their work appears in journals such as Annals of Oncology, International Journal of Cancer and Journal of Clinical Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026